LANXESS Aktiengesellschaft
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative soluti… Read more
LANXESS Aktiengesellschaft (LNXSY) - Total Liabilities
Latest total liabilities as of September 2025: $4.28 Billion USD
Based on the latest financial reports, LANXESS Aktiengesellschaft (LNXSY) has total liabilities worth $4.28 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
LANXESS Aktiengesellschaft - Total Liabilities Trend (2003–2024)
This chart illustrates how LANXESS Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
LANXESS Aktiengesellschaft Competitors by Total Liabilities
The table below lists competitors of LANXESS Aktiengesellschaft ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
STCube Inc
KQ:052020
|
Korea | ₩15.81 Billion |
|
Hunan Fangsheng Pharm Co Ltd
SHG:603998
|
China | CN¥1.28 Billion |
|
IntelliEPI Cayman
TWO:4971
|
Taiwan | NT$105.65 Million |
|
Merida Industry Co Ltd
TW:9914
|
Taiwan | NT$16.65 Billion |
|
Kirloskar Brothers Limited
NSE:KIRLOSBROS
|
India | ₹15.61 Billion |
|
HCM II Acquisition Corp. Unit
NASDAQ:HONDU
|
USA | $15.00 Million |
Liability Composition Analysis (2003–2024)
This chart breaks down LANXESS Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LANXESS Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LANXESS Aktiengesellschaft (2003–2024)
The table below shows the annual total liabilities of LANXESS Aktiengesellschaft from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.12 Billion | -0.76% |
| 2023-12-31 | $5.16 Billion | -24.74% |
| 2022-12-31 | $6.85 Billion | +1.45% |
| 2021-12-31 | $6.76 Billion | +14.88% |
| 2020-12-31 | $5.88 Billion | -2.76% |
| 2019-12-31 | $6.05 Billion | +2.27% |
| 2018-12-31 | $5.91 Billion | -15.31% |
| 2017-12-31 | $6.98 Billion | +13.56% |
| 2016-12-31 | $6.15 Billion | +25.59% |
| 2015-12-31 | $4.90 Billion | -3.79% |
| 2014-12-31 | $5.09 Billion | +3.62% |
| 2013-12-31 | $4.91 Billion | -5.34% |
| 2012-12-31 | $5.19 Billion | +7.99% |
| 2011-12-31 | $4.80 Billion | +23.02% |
| 2010-12-31 | $3.90 Billion | +7.78% |
| 2009-12-31 | $3.62 Billion | +11.68% |
| 2008-12-31 | $3.24 Billion | +28.53% |
| 2007-12-31 | $2.52 Billion | -9.11% |
| 2006-12-31 | $2.78 Billion | -9.98% |
| 2005-12-31 | $3.08 Billion | -3.95% |
| 2004-12-31 | $3.21 Billion | +2.62% |
| 2003-12-31 | $3.13 Billion | -- |